Open-Label Phase II Prospective, Randomized, Controlled Study of Romyelocel-L Myeloid Progenitor Cells to Reduce Infection During Induction Chemotherapy for Acute Myeloid Leukemia

Pinkal M. Desai, Janice Brown, Saar Gill, Melham M. Solh, Luke P. Akard, Jack W. Hsu, Celalettin Ustun, Charalambos Andreadis, Olga Frankfurt, James M. Foran, John Lister, Gary J. Schiller, Matthew J. Wieduwilt, John M. Pagel, Patrick J. Stiff, Delong Liu, Irum Khan, Wendy Stock, Suman Kambhampati, Martin S. TallmanLawrence Morris, John Edwards, Iskra Pusic, Hagop M. Kantarjian, Richard Mamelok, Alicia Wong, Rodney Van Syoc, Lois Kellerman, Swapna Panuganti, Ramkumar Mandalam, Camille N. Abboud, Farhad Ravandi

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'Open-Label Phase II Prospective, Randomized, Controlled Study of Romyelocel-L Myeloid Progenitor Cells to Reduce Infection During Induction Chemotherapy for Acute Myeloid Leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences